E6-14293. Psychopharmacologic Drugs Advisory Committee; Cancellation  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The meeting of the Psychopharmacologic Drugs Advisory Committee scheduled for September 7, 2006, is cancelled. This amended meeting was announced in the Federal Register of August 17, 2006 (71 FR 47502).

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Cicely Reese, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: cicely.reese@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512544. Please call the Information Line for up-to-date information on this meeting.

    Start Signature

    Dated: August 23, 2006.

    Randall W. Lutter,

    Associate Commissioner for Policy and Planning.

    End Signature End Further Info End Preamble

    [FR Doc. E6-14293 Filed 8-28-06; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
08/29/2006
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
E6-14293
Pages:
51198-51198 (1 pages)
PDF File:
e6-14293.pdf